Tudtud, Maricel .

HRN: 21-02-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
CEFUROXIME 1.5GM (VIAL)
05/29/2025
05/30/2025
IV
1.5g
Q8hrs
PROM
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines